What is Merck & Co.'s cumulative gross losses and impairments?

Merck & Co. (MRK) reported cumulative gross losses and impairments of $531.00M in Q4 2025.

How has Merck & Co.'s cumulative gross losses and impairments changed year-over-year?

Merck & Co.'s cumulative gross losses and impairments decreased by 0.0% year-over-year, from $531.00M to $531.00M.

What is the long-term trend for Merck & Co.'s cumulative gross losses and impairments?

Over 5 years (2020 to 2025), Merck & Co.'s cumulative gross losses and impairments has grown at a 0.0% compound annual growth rate (CAGR), from $531.00M to $531.00M.

What does cumulative gross losses and impairments mean?

The total amount of unrealized losses and impairment charges taken on investments.

Equity

Cumulative Gross Losses and Impairments

Merck & Co. Cumulative Gross Losses and Impairments remained flat by 0.0% to $531.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $531.00M to $531.00M. Over 5 years (FY 2020 to FY 2025), Cumulative Gross Losses and Impairments shows relatively stable performance with a 0.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionEquity

CategoryRisk

SignalLower is better

VolatilityModerate

First reportedQ4 2014

Last reportedQ4 2025Feb 24, 2026

How to read this metric

An increase indicates deteriorating value in the investment portfolio, while a decrease suggests recovery or disposal of impaired assets.

Detailed definition

This represents the total historical unrealized losses and impairment charges recorded against investment assets that ha...

Peer comparison

Standard metric for firms with significant investment portfolios; peers in the same sector should have similar impairment profiles.

Metric ID: cumulative_gross_losses_and_impairments

Historical Data

5 periods

	Q4 '21	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$531.00M	$531.00M	$531.00M	$531.00M	$531.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	+0.0%	+0.0%	+0.0%	+0.0%

Range$531.00M – $531.00M

CAGR+0.0%

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Current Streak4+ quarters growth

Cumulative Gross Losses and Impairments at Other Companies

ZoetisZTS View metric

Frequently Asked Questions

What is Merck & Co.'s cumulative gross losses and impairments?: Merck & Co. (MRK) reported cumulative gross losses and impairments of $531.00M in Q4 2025.
How has Merck & Co.'s cumulative gross losses and impairments changed year-over-year?: Merck & Co.'s cumulative gross losses and impairments decreased by 0.0% year-over-year, from $531.00M to $531.00M.
What is the long-term trend for Merck & Co.'s cumulative gross losses and impairments?: Over 5 years (2020 to 2025), Merck & Co.'s cumulative gross losses and impairments has grown at a 0.0% compound annual growth rate (CAGR), from $531.00M to $531.00M.
What does cumulative gross losses and impairments mean?: The total amount of unrealized losses and impairment charges taken on investments.